Clinical Trial Update: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of gossypol, paclitaxel, and carboplatin in patients with metastatic or unresectable solid tumors, including various ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Diffuse Large B-cell Lymphoma
• Extranodal Nk T-cell Lymphoma Nasal Type
• Follicular Lymphoma
• Lymphomatoid Granulomatosis
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gossypol (gossypol)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | Phase 1 | Status: COMPLETED